Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.

Lopes RD, Heizer G, Aronson R, Vora AN, Massaro T, Mehran R, Goodman SG, Windecker S, Darius H, Li J, Averkov O, Bahit MC, Berwanger O, Budaj A, Hijazi Z, Parkhomenko A, Sinnaeve P, Storey RF, Thiele H, Vinereanu D, Granger CB, Alexander JH; AUGUSTUS Investigators.

N Engl J Med. 2019 Apr 18;380(16):1509-1524. doi: 10.1056/NEJMoa1817083. Epub 2019 Mar 17.

PMID:
30883055
2.

Procedural, Functional and Prognostic Outcomes Following Recanalization of Coronary Chronic Total Occlusions. Results of the Iberian Registry.

Amat-Santos IJ, Martin-Yuste V, Fernández-Díaz JA, Martin-Moreiras J, Caballero-Borrego J, Salinas P, Ojeda S, Rivero F, Núñez Villota J, Mohandes M, Dubois D, Bosa Ojeda F, Rumiz E, de la Torre Hernández JM, Jiménez-Mazuecos J, Lacunza J, Tejedor P, Gómez I, Goncalves-Ramirez LR, Rojas P, Sabaté M, Goicolea J, Diego Nieto A, Jiménez-Fernández M, Escaned J, Gonzalo N, Pardo L, Cuesta J, Miñana G, Sanchis J, Rojas S, Millán R, Vaquerizo B, Rodríguez S, Lee DH, Morales FJ, Gutiérrez A, López M, Maristany J, Rondán J, Galeote G, Kabbanni Z, Rodríguez S, Teruel L, Sadaba M, Jurado A, Mainar V, Sánchez-Rubio J, Vinhas H, Fernandes R.

Rev Esp Cardiol (Engl Ed). 2019 May;72(5):373-382. doi: 10.1016/j.rec.2018.05.020. Epub 2018 Jun 25. English, Spanish.

PMID:
29954721
3.

Long-term prognostic impact of anticoagulation on patients with atrial fibrillation undergoing hemodialysis.

Sánchez Soriano RM, Albero Molina MD, Chamorro Fernández CI, Juliá-Sanchís R, López Menchero R, Del Pozo Fernández C, Grau Jornet G, Núñez Villota J.

Nefrologia. 2018 Jul - Aug;38(4):394-400. doi: 10.1016/j.nefro.2017.11.026. Epub 2018 Feb 6. English, Spanish.

4.

[Comparison of the efficacy and safety of dronedarone and flecainide as maintenance antiarrhythmic therapy for sinus rhythm in atrial fibrillation].

Sánchez Soriano RM, Chamorro Fernández CI, Ruiz Nodar JM, Chamorro Fernández AJ, Grau Jornet G, Nuñez Villota J.

Arch Cardiol Mex. 2018 Jul - Sep;88(3):204-211. doi: 10.1016/j.acmx.2017.07.009. Epub 2017 Aug 30. Spanish.

PMID:
28864237
5.

What would be the fate of the association between saxagliptin and heart failure admission in the SAVOR-TIMI 53 trial if appropriate statistical methods should have been applied?

Cebrián-Cuenca AM, Núñez E, Núñez-Villota J, Consuegra-Sánchez L.

Diabetes Res Clin Pract. 2017 Apr;126:320-321. doi: 10.1016/j.diabres.2017.02.029. Epub 2017 Mar 9. No abstract available.

PMID:
28341488
6.

Saxagliptin and Heart Failure in the SAVOR-TIMI 53 Trial: Reflections on the Bradford Hill Criteria.

Cebrián Cuenca AM, Orozco Beltrán D, Navarro Pérez J, Álvarez-Guisasola F, Núñez Villota J, Consuegra-Sánchez L.

Rev Esp Cardiol (Engl Ed). 2017 Dec;70(12):1143-1144. doi: 10.1016/j.rec.2017.02.023. Epub 2017 Mar 9. Review. English, Spanish. No abstract available.

PMID:
28284632
7.

Saxagliptin and risk of heart failure hospitalization: Concern or miscalculation?

Cebrián-Cuenca AM, Orozco-Beltrán D, Navarro-Pérez J, Franch-Nadal J, Núñez-Villota J, Consuegra-Sánchez L.

Int J Cardiol. 2016 Oct 1;220:573-4. doi: 10.1016/j.ijcard.2016.06.269. Epub 2016 Jun 29. No abstract available.

PMID:
27390991
8.

Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).

McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau J, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Committees and Investigators.

Eur J Heart Fail. 2013 Sep;15(9):1062-73. doi: 10.1093/eurjhf/hft052. Epub 2013 Apr 5.

9.

[Red cell distribution width and mortality risk in acute heart failure patients].

Olivares Jara M, Santas Olmeda E, Miñana Escrivà G, Palau Sampio P, Merlos Díaz P, Sanchis Forés J, Núñez Villota J.

Med Clin (Barc). 2013 May 13;140(10):433-8. doi: 10.1016/j.medcli.2012.09.044. Epub 2013 Jan 18. Spanish.

PMID:
23337456
10.

Differences in outcome of heart failure with preserved or depressed systolic function in patients older than 70 years who receive beta blockers.

Anguita M, Castillo JC, Ruiz M, Castillo F, Jiménez-Navarro M, Crespo M, Alonso-Pulpón L, de Teresa E, Castro-Beiras A, Roig E, Artigas R, Zapata A, de Ullibarri IL, Muñiz J; OBELICA Study Researchers.

Rev Esp Cardiol (Engl Ed). 2012 Jan;65(1):22-8. doi: 10.1016/j.recesp.2011.07.011. Epub 2011 Oct 15. English, Spanish.

PMID:
22001308
11.

Effect of a training program for primary care physicians on the optimization of beta-blocker treatment in elderly patients with heart failure.

Anguita Sánchez M, Jiménez-Navarro M, Crespo M, Alonso-Pulpón L, de Teresa E, Castro-Beiras A, Roig E, Artigas R, Zapata A, López de Ulibarri I, Muñiz J; OBELICA study researchers.

Rev Esp Cardiol. 2010 Jun;63(6):677-85.

12.

[Predictive value of chest pain score for the diagnosis of acute coronary syndromes].

Ruiz-Ros V, Sanchis-Forés J, Bodí-Peris V, Núñez-Villota J, Gómez-Monsoliu C, Bosch-Campos MJ, Ruiz-Aguilar C, Llàcer-Escorihuela A.

Med Clin (Barc). 2006 Jan 14;126(1):1-4. Spanish.

PMID:
16409943
13.

[Influence of comorbidity on admission management and pharmacological treatment prescribed at discharge in acute myocardial infarction].

Fácila Rubio L, Núñez Villota J, Bertomeu González V, Sanchís Fores J, Bodi Peris V, Consuegra Sánchez L, Sanjuán Mañez R, Llácer Escorihuela A.

Med Clin (Barc). 2005 Apr 2;124(12):447-50. Spanish.

PMID:
15826580
14.

Hemoptysis as an unusual manifestation of right atrial myxoma.

Fácila-Rubio L, Nuñez-Villota JE, Losada-Casares A, Otero-Coto E, Marin-Pardo J, Ferreres-Franco J, Chorro-Gascó FJ.

Int J Cardiol. 2003 Jan;87(1):103-5.

PMID:
12468061

Supplemental Content

Loading ...
Support Center